Organigram appoints Yamanaka as CEO

Executive Summary

• Organigram Global Inc. has appointed James Yamanaka as its new Chief Executive Officer, effective on or about January 15, 2026.
• Yamanaka brings over 20 years of experience from British American Tobacco (BAT), where he served as Global Head of Strategy and previously led operations in North Asia and Northern Europe.
• Peter Amirault, the current board chairman, will serve as interim executive chair starting December 1 to oversee day-to-day management until Yamanaka assumes the role.

Key Details

• New CEO: James Yamanaka, formerly Global Head of Strategy for British American Tobacco.
• Effective Date: On or about January 15, 2026.
• Board Role: Yamanaka will join the company's board of directors concurrently with his appointment as CEO.
• Interim Leadership: Peter Amirault (current board chairman) appointed as executive chair on an interim basis effective December 1.
• Independent Lead Director: Geoff Machum (chair of the board's governance, nominating and sustainability committee) will serve as independent lead director during the interim period.
• Yamanaka’s Background:
  • Over 20 years at British American Tobacco.
  • Instrumental in developing BAT group strategy as Global Head of Strategy.
  • Former Area Director for North Asia (Japan and South Korea), achieving record market share in Japan.
  • Transformed BAT's Northern Europe Area into a position for rapid sustainable growth via the acquisition of a nicotine pouch business.
• Education: BA in political science and economics from UC San Diego; MS in foreign service from Georgetown University; MBA from London Business School.
• Location: Based in Toronto, Ontario.
• Conditions: Appointment is subject to completion of customary immigration matters.

Notable Quotes

• Peter Amirault, Executive Chair: "We are excited to have James join the Organigram team. James's history of driving strong international growth aligns perfectly with Organigram's global aspirations. His experience in building high-performing teams and delivering results will be invaluable as we expand our international presence."
• James Yamanaka, New CEO: "I am thrilled to take on this new challenge. I have watched Organigram evolve into Canada's No. 1 recreational cannabis company by market share and believe it is well positioned to become a global leader in the cannabis industry. I look forward to building an international presence on Organigram's strong foundation of high-quality products, trusted brands and a commitment to industry-leading innovation."